The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 16, 2019
Filed:
Nov. 28, 2016
Applicant:
Medicinal Bioconvergence Research Center, Gyeonggi-do, KR;
Inventors:
Sunghoon Kim, Seoul, KR;
Min Chul Park, Gyeonggi-do, KR;
Assignee:
MEDICINAL BIOCONVERGENCE RESEARCH CENTER, Gyeonggi-Do, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/00 (2006.01); A61K 38/53 (2006.01); A61K 38/43 (2006.01); C12P 21/00 (2006.01); A61K 38/17 (2006.01);
U.S. Cl.
CPC ...
A61K 38/53 (2013.01); A61K 38/1709 (2013.01); A61K 38/179 (2013.01); A61K 38/43 (2013.01); C12N 9/00 (2013.01); C12N 9/93 (2013.01); C12P 21/00 (2013.01); C12Y 601/01004 (2013.01); C12Y 601/01005 (2013.01); C12Y 601/01014 (2013.01);
Abstract
The present invention relates to nanoparticles comprising aminoacyl tRNA synthetase and an anticancer composition comprising the same and, specifically, to nanoparticles which comprise glycyl-tRNA synthetase (GRS), leucyl-tRNA synthetase (LRS), and isoleucyl-tRNA synthetase (IRS), and have anticancer or immunostimulating activity; a pharmaceutical composition for preventing or treating cancer, comprising the nanoparticles as an active ingredient; a composition for immunostimulation; and a method for preparing the nanoparticles.